$FENC has a nice short signal, the stock had a spectacular rally since it bottomed in early 2022, but could be reaching the end of the road here after drastically outperforming the market until now. Their drug received FDA approval in Sep 2022, commercial availability in the US in Oct 2022, but despite this, the latest report showed an increase in net loss YoY...
We have a nice chance to enter longs here with a tight stop loss. We can jump in right now, or wait for a few hours if more conservative. Stop loss is 5145.08, if we go below it, we might get a correction in weekly scale, so ideally, we stay above it.
Timing the entry would help with getting in and seeing profits instantly. If you jump in now, although price is...